ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/03/03 | 1,870 | 1,904 | 1,832 | 1,843 | -22 | -1.2% | 473,500 |
2021/03/02 | 1,817 | 1,878 | 1,813 | 1,865 | +10 | +0.5% | 381,700 |
2021/03/01 | 1,850 | 1,862 | 1,827 | 1,855 | +12 | +0.7% | 343,500 |
2021/02/26 | 1,820 | 1,883 | 1,784 | 1,843 | -2 | -0.1% | 651,700 |
2021/02/25 | 1,870 | 1,880 | 1,823 | 1,845 | +26 | +1.4% | 627,600 |
2021/02/24 | 1,804 | 1,845 | 1,787 | 1,819 | -4 | -0.2% | 852,500 |
2021/02/22 | 1,828 | 1,829 | 1,789 | 1,823 | +11 | +0.6% | 612,100 |
2021/02/19 | 1,848 | 1,871 | 1,760 | 1,812 | -60 | -3.2% | 1,242,800 |
2021/02/18 | 1,890 | 1,937 | 1,869 | 1,872 | -23 | -1.2% | 655,600 |
2021/02/17 | 1,937 | 1,945 | 1,883 | 1,895 | -50 | -2.6% | 746,900 |
2021/02/16 | 2,025 | 2,029 | 1,936 | 1,945 | -55 | -2.8% | 744,900 |
2021/02/15 | 1,970 | 2,040 | 1,942 | 2,000 | +142 | +7.6% | 1,601,100 |
2021/02/12 | 1,894 | 1,894 | 1,845 | 1,858 | -48 | -2.5% | 607,500 |
2021/02/10 | 1,904 | 1,933 | 1,894 | 1,906 | -15 | -0.8% | 317,400 |
2021/02/09 | 1,955 | 1,957 | 1,888 | 1,921 | -45 | -2.3% | 762,300 |
2021/02/08 | 1,988 | 1,994 | 1,963 | 1,966 | -22 | -1.1% | 467,300 |
2021/02/05 | 1,990 | 2,000 | 1,966 | 1,988 | -5 | -0.3% | 590,700 |
2021/02/04 | 2,025 | 2,032 | 1,972 | 1,993 | -32 | -1.6% | 480,700 |
2021/02/03 | 2,004 | 2,050 | 1,995 | 2,025 | +31 | +1.6% | 667,300 |
2021/02/02 | 2,048 | 2,059 | 1,993 | 1,994 | -47 | -2.3% | 696,400 |
2021/02/01 | 1,961 | 2,048 | 1,960 | 2,041 | +71 | +3.6% | 679,300 |
2021/01/29 | 1,970 | 2,048 | 1,958 | 1,970 | -21 | -1.1% | 931,800 |
2021/01/28 | 1,970 | 2,004 | 1,966 | 1,991 | -29 | -1.4% | 779,900 |
2021/01/27 | 2,000 | 2,047 | 1,974 | 2,020 | +20 | +1% | 631,000 |
2021/01/26 | 2,075 | 2,078 | 1,991 | 2,000 | -77 | -3.7% | 1,036,100 |
2021/01/25 | 2,089 | 2,098 | 2,033 | 2,077 | +9 | +0.4% | 514,400 |
2021/01/22 | 2,047 | 2,104 | 2,045 | 2,068 | -1 | ±0% | 982,100 |
2021/01/21 | 1,982 | 2,086 | 1,981 | 2,069 | +88 | +4.4% | 1,392,800 |
2021/01/20 | 1,960 | 1,999 | 1,946 | 1,981 | +50 | +2.6% | 814,200 |
2021/01/19 | 1,979 | 1,987 | 1,927 | 1,931 | -40 | -2% | 647,200 |
2021/01/18 | 1,930 | 2,022 | 1,929 | 1,971 | +23 | +1.2% | 1,193,900 |
2021/01/15 | 1,948 | 1,976 | 1,931 | 1,948 | +3 | +0.2% | 816,300 |
2021/01/14 | 1,929 | 1,978 | 1,920 | 1,945 | ±0 | ±0% | 769,900 |
2021/01/13 | 1,998 | 2,040 | 1,936 | 1,945 | -54 | -2.7% | 1,338,000 |
2021/01/12 | 1,936 | 2,059 | 1,921 | 1,999 | +39 | +2% | 2,130,700 |
2021/01/08 | 1,897 | 1,986 | 1,885 | 1,960 | +91 | +4.9% | 2,239,600 |
2021/01/07 | 1,830 | 1,910 | 1,828 | 1,869 | +105 | +6% | 2,103,800 |
2021/01/06 | 1,688 | 1,777 | 1,655 | 1,764 | +53 | +3.1% | 1,754,900 |
2021/01/05 | 1,768 | 1,768 | 1,697 | 1,711 | -59 | -3.3% | 955,600 |
2021/01/04 | 1,808 | 1,821 | 1,757 | 1,770 | -30 | -1.7% | 733,500 |
2020/12/30 | 1,807 | 1,831 | 1,791 | 1,800 | -20 | -1.1% | 540,300 |
2020/12/29 | 1,822 | 1,852 | 1,816 | 1,820 | +19 | +1.1% | 662,400 |
2020/12/28 | 1,809 | 1,840 | 1,754 | 1,801 | -48 | -2.6% | 1,391,600 |
2020/12/25 | 1,830 | 1,900 | 1,830 | 1,849 | -1 | -0.1% | 1,646,600 |
2020/12/24 | 1,765 | 1,863 | 1,764 | 1,850 | +125 | +7.2% | 2,447,500 |
2020/12/23 | 1,736 | 1,793 | 1,700 | 1,725 | -20 | -1.1% | 2,222,600 |
2020/12/22 | 1,645 | 1,765 | 1,644 | 1,745 | +100 | +6.1% | 2,954,700 |
2020/12/21 | 1,699 | 1,699 | 1,612 | 1,645 | +97 | +6.3% | 1,502,200 |
2020/12/18 | 1,538 | 1,558 | 1,528 | 1,548 | +4 | +0.3% | 371,500 |
2020/12/17 | 1,552 | 1,566 | 1,540 | 1,544 | -8 | -0.5% | 359,900 |
1051~
1100
件表示中 / 5112件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 90,000円 | +20.3% | - | 0.00% | 159.57倍 | 1.19倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
ハートシード | 366,500円 | +174.2% | - | 0.00% | - | 11.00倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
栄研化 | 212,900円 | +4.1% | -3.1% | 2.72% | 18.54倍 | 1.62倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
JCRファーマ | 54,800円 | +14.3% | - | 3.65% | 22.26倍 | 1.42倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
あすかHD | 232,900円 | +16.9% | +33.2% | 2.36% | 12.70倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム